Appointed
Michael Galloro
Director
TBH ·
Brag House Holdings, Inc.
Michael Galloro 51 Director
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1001–1050 of 76231
Appointed
Duncan Moir
Director
TBH ·
Brag House Holdings, Inc.
Duncan Moir 41 Director
Appointed
Marco Margiotta
Chief Executive Officer
TBH ·
Brag House Holdings, Inc.
Marco Margiotta 46 Chief Executive Officer
Appointed
Sarosh Mistry
Director
TBH ·
Brag House Holdings, Inc.
Sarosh Mistry 56 Director
Appointed
Stephen Ilott
Director
TBH ·
Brag House Holdings, Inc.
Stephen Ilott 58 Director
Appointed
Charles Park
Chief Financial Officer
TBH ·
Brag House Holdings, Inc.
Charles Park 50 Chief Financial Officer
Appointed
Yassine Bouhara
Director
VII ·
Viking Acquisition Corp. II
When the election of Dr. Ackermann and Messrs. Brettschneider, Bouhara and Waugh as directors of the Company became effective on July 6, 2026, each of them entered into an indemnity agreement with the Company.
Appointed
Dr. Josef Ackermann
Director
VII ·
Viking Acquisition Corp. II
When the election of Dr. Ackermann and Messrs. Brettschneider, Bouhara and Waugh as directors of the Company became effective on July 6, 2026, each of them entered into an indemnity agreement with the Company.
Appointed
Seth Waugh
Director
VII ·
Viking Acquisition Corp. II
When the election of Dr. Ackermann and Messrs. Brettschneider, Bouhara and Waugh as directors of the Company became effective on July 6, 2026, each of them entered into an indemnity agreement with the Company.
Appointed
Fred Brettschneider
Director
VII ·
Viking Acquisition Corp. II
When the election of Dr. Ackermann and Messrs. Brettschneider, Bouhara and Waugh as directors of the Company became effective on July 6, 2026, each of them entered into an indemnity agreement with the Company.
Departed
Chris Sambar
Chief Operating Officer
PSA ·
Public Storage
On July 2, 2026, Chris Sambar, the Chief Operating Officer of Public Storage (the “Company”), resigned effective at the end of July to join T-Mobile as Chief Enterprise Officer.
Appointed
Donn Casale
Chief Executive Officer
SPRY ·
ARS Pharmaceuticals, Inc.
On July 7, 2026, the Board of Directors (the “Board”) of ARS Pharmaceuticals, Inc. (the “Company”) appointed the Company’s current President Donn Casale as the Company’s Chief Executive Officer, effective immediately, replacing Richard Lowenthal in such capacity.
Appointed
Donn Casale
Class III director
SPRY ·
ARS Pharmaceuticals, Inc.
Mr. Casale was also concurrently appointed to the Board as a Class III director, to serve until the Company’s 2029 annual meeting of stockholders.
Departed
Richard Lowenthal
Chief Executive Officer
SPRY ·
ARS Pharmaceuticals, Inc.
Mr. Lowenthal was notified on July 6, 2026 that his employment was being terminated without cause, effective immediately.
Departed
Steven Dassing
Vice President, Corporate Controller and Principal Accounting Officer
KWR ·
QUAKER CHEMICAL CORP
On June 30, 2026, Steven Dassing resigned from his position as Vice President, Corporate Controller and Principal Accounting Officer of Quaker Chemical Corporation (“Quaker Houghton” or the “Company”) effective July 22, 2026.
Role change
Robert Coler
Principal Accounting Officer
KWR ·
QUAKER CHEMICAL CORP
Upon the effectiveness of Mr. Dassing’s resignation, Mr. Coler, age 53, will serve as the Company’s Principal Accounting Officer, in addition to his current position as Executive Vice President, Chief Financial Officer.
Appointed
Manuel Benito Miranda
Class II Director
MTZ ·
MASTEC INC
On June 30, 2026, the Board of Directors (the “Board”) of the Company appointed Mr. Manuel Benito Miranda as a Class II director to fill a vacancy in that Board Class following an increase in the size of the Board from eight (8) to nine (9) directors.
Departed
(interim)
Michael Buhle
Chief Executive Officer
AWHL ·
Aspira Women's Health Inc.
Michael Buhle ceased serving as the Company’s Chief Executive Officer effective June 17, 2026
Appointed
(interim)
John (Jack) Fraser
Interim Chief Executive Officer
AWHL ·
Aspira Women's Health Inc.
appointed John (Jack) Fraser as Interim Chief Executive Officer
Role change
André Almeida
Chief Marketing, Brand and Broadband Officer
TMUS ·
T-Mobile US, Inc.
In connection with Mr. Sambar’s hiring, André Almeida, currently the Company’s Chief Broadband, Enterprise and Emerging Business Officer, will transition to the role of Chief Marketing, Brand, and Broadband Officer.
Role change
Dr. John Saw
Chief Technology Officer
TMUS ·
T-Mobile US, Inc.
Additionally, Dr. John Saw, the Company’s Chief Technology Officer, will expand his purview to include product engineering and cybersecurity, in addition to his existing responsibilities.
Departed
Michael J. Katz
Chief Business and Product Officer
TMUS ·
T-Mobile US, Inc.
After over two decades in various leadership positions with the Company, Michael J. Katz, the Company’s Chief Business and Product Officer, has decided to step away from his position at the Company effective July 8, 2026, but he will remain with the Company as a strategic advisor through December 2026.
Appointed
Chris Sambar
Chief Enterprise Officer
TMUS ·
T-Mobile US, Inc.
T-Mobile US, Inc. (the “Company”) announced that it has appointed Chris Sambar as its Chief Enterprise Officer, effective no later than October 14, 2026.
Appointed
Lori Goltermann
Director
LFST ·
LifeStance Health Group, Inc.
on July 2, 2026, the Board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as a directors of the Company.
Appointed
Safwan Shabab
Director
LFST ·
LifeStance Health Group, Inc.
on July 2, 2026, the Board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as a directors of the Company.
Appointed
Thurman Justice
Director
LFST ·
LifeStance Health Group, Inc.
on July 2, 2026, the Board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as a directors of the Company.
Departed
Jeffrey Rhodes
Director
LFST ·
LifeStance Health Group, Inc.
On July 2, 2026, Jeffrey Rhodes notified the LifeStance Health Group, Inc. (the “Company”) board of directors (the “Board”) of his resignation from the Board and all of its committees, effective immediately.
Departed
Stephen Markscheid
Director
Four Leaf Acquisition Corp
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
Departed
Alvin Wang
Director
Four Leaf Acquisition Corp
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
Departed
Coco Kou
Chief Financial Officer
Four Leaf Acquisition Corp
Effective July 7, 2026, Ms. Coco Kou, Chief Financial Officer of the Company resigned from her position with the Company, effective immediately.
Appointed
Nanuk Warman
Independent Director
Four Leaf Acquisition Corp
Effective as of July 7, 2026, each of Nanuk Warman, Jay Izso and Mark DiSabato was appointed as independent director to the Company’s Board of Directors.
Departed
Rahul Mewawalla
Director
Four Leaf Acquisition Corp
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
Appointed
Mark DiSabato
Independent Director
Four Leaf Acquisition Corp
Effective as of July 7, 2026, each of Nanuk Warman, Jay Izso and Mark DiSabato was appointed as independent director to the Company’s Board of Directors.
Appointed
Jay Izso
Independent Director
Four Leaf Acquisition Corp
Effective as of July 7, 2026, each of Nanuk Warman, Jay Izso and Mark DiSabato was appointed as independent director to the Company’s Board of Directors.
Departed
Carson Heagen
Chief Operating Officer
XPON ·
Expion360 Inc.
On July 2, 2026, Carson Heagen, the Chief Operating Officer of Expion360 Inc. (the “Company”), notified the board of directors of the Company that he is resigning from his role as Chief Operating Officer, effective August 1, 2026, due to personal reasons.
Appointed
(interim)
Jerome T. Upton
Interim President and Chief Executive Officer
GNW ·
GENWORTH FINANCIAL INC
Jerome T. Upton, the Company’s current Executive Vice President and Chief Financial Officer (Principal Financial Officer), has been appointed Interim President and Chief Executive Officer (Principal Executive Officer), effective July 7, 2026.
Role change
Thomas J. McInerney
President & Chief Executive Officer
GNW ·
GENWORTH FINANCIAL INC
Thomas J. McInerney, President & Chief Executive Officer, will be taking a temporary leave of absence from his role to focus on his health.
Departed
Shawn Morris
member of the Board of Directors
PRVA ·
Privia Health Group, Inc.
On July 6, 2026, Shawn Morris resigned from his position as a member of the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) and as a member of the Compliance Committee of the Board, effective immediately.
Departed
Andrew Levin
Director
VOR ·
Vor Biopharma Inc.
On July 6, 2026, Andrew Levin, M.D., Ph.D., a member of the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”), delivered his notice of resignation, effective immediately.
Appointed
David Zaccardelli
Director
VOR ·
Vor Biopharma Inc.
On July 7, 2026, the Board appointed David Zaccardelli, Pharm.D. to the vacancy created by Dr. Levin’s resignation, to serve on the Board as an independent Class II director until the Company’s 2029 annual meeting of stockholders and until his successor is duly elected and qualified or his earlier resignation or removal.
Appointed
Gregory R. Allen
Director
FMAO ·
FARMERS & MERCHANTS BANCORP INC
On June 30, 2026, the Board of Directors of Farmers & Merchants Bancorp, Inc. (the “Company”) determined to appoint Gregory R. Allen to fill an open vacancy on its Board of Directors.
Departed
Michael D. Hill
Chief Financial Officer
UPLD ·
Upland Software, Inc.
On June 30, 2026, Michael D. Hill, Chief Financial Officer of Upland Software, Inc. (the “Company”) notified the board of directors of the Company (the “Board”) of his intention to retire as Chief Financial Officer, effective July 27, 2026 (the “Effective Date”).
Appointed
(interim)
David Tamez
Interim Chief Financial Officer
UPLD ·
Upland Software, Inc.
On July 6, 2026, the Board appointed David Tamez to serve as the interim Chief Financial Officer of the Company, effective as of the Effective Date, until a permanent successor is identified.
Departed
Lori M. Toomey
Director
Kingfish Holding Corp
Lori M. Toomey, a member of the Board of Directors (the “Board”) of Kingfish Holding Corporation (the “Company”), has advised the Company on June 30, 2026, that she has determined not to stand for re-election at the Company’s 2027 annual meeting of shareholders.
Role change
Jason Slutsky
Chief Operating Officer and General Counsel
GRAHAM ALTERNATIVE INVESTMENT FUND I LLC
Additionally , effective as of June 26, 2026 , the Manager promoted Jason Slutsky , previously the General Counsel of the Manager , to Chief Operating Officer and General Counsel .
Departed
Brian Douglas
Chief Executive Officer
GRAHAM ALTERNATIVE INVESTMENT FUND I LLC
Eff e cti v e June 26 , 2026, Brian Douglas , previously the Chief Executive Officer of Graham Capital Management , L.P., the manag e r (the "Manager") of Graham Alternative Investment Fund I LLC (the "Company"), retired from his role at the Manager.
Departed
Brian Douglas
Chief Executive Officer
GRAHAM ALTERNATIVE INVESTMENT FUND II LLC
Effective June 26, 2026, Brian Douglas, previously the Chief Executive Officer of Graham Capital Management, L.P., the manager (the "Manager") of Graham Alternative Investment Fund II LLC (the "Company"), retired from his role at the Manager.
Role change
Jason Slutsky
Chief Operating Officer and General Counsel
GRAHAM ALTERNATIVE INVESTMENT FUND II LLC
Additionally, effective as of June 26, 2026, the Manager promoted Jason Slutsky, previously the General Counsel of the Manager, to Chief Operating Officer and General Counsel.
Departed
Amanda Baldwin
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Departed
Martha Morfitt
Director
OLPX ·
OLAPLEX HOLDINGS, INC.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.